Get started
Live feed
PRReleasevia Quantisnow
BioRestorative Therapies Inc. logo

BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for BRTX

Across the 19 sessions after earlier BRTX headlines, the stock closed higher 6 times and lower 13 times, with a median move of 7.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

BRTX close-to-close change in the session after earlier headlines
SessionEarlier headlineBRTXSPY
May 13, 2026BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals-5.8%+0.6%
May 7, 2026BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease-8.1%-0.3%
Apr 30, 2026BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform+11.6%+1.0%
Apr 21, 2026BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform-7.8%-0.7%
Apr 7, 2026BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform-0.1%+0.0%
Mar 30, 2026BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease-10.9%-0.3%

Keep researching BRTX

Quantisnow market dataNASDAQ
BioRestorative Therapies Inc. logo
BRTX
BioRestorative Therapies Inc.
Market cap
30-day
Sector
Health Care
Industry
Managed Health Care
Get push alerts for BRTX

Follow BRTX and get a push notification the moment its next story breaks.

Full BRTX profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BRTX (BioRestorative Therapies Inc.) and more on Quantisnow.